Department of Nutrition, Food Studies, and Public Health

Faculty

Farzana Kapadia

Assistant Professor of Public Health & Population Health

Farzana Kapadia

Phone: 212.998.5223
Email:

Farzana Kapadia is an epidemiologist whose research seeks to understand the distribution, determinants and consequences of HIV/AIDS across the lifespan.  Dr. Kapadia conducts research that explores contextual factors influencing HIV/AIDS risk and related outcomes among vulnerable and, often marginalized adolescents and young adults.  Second, given the chronic nature of HIV/AIDS, her research also seeks to understand the impact of HIV/AIDS on the physical, mental, and behavioral health of older, HIV+ adults. Across these lines of inquiry, her focus is on how contextual factors such as social and sexual network level factors, promote the diffusion of information, disease risk or disease progression.  Thus, her research focuses on the salience of social and sexual networks in creating opportunities to engage in HIV related risk behavior but also as a means of promoting resilience to HIV/AIDS and its associated outcomes. Dr. Kapadia is the Co-Director at CHIBPS  and is affiliated with the Department of Population Health at the Langone School of Medicine and the Institute of Human Develpment and Social Change

In addition to her research, Dr. Kapadia teaches the introductory epidemiology course at both the graduate and undergraduate levels and has also taught courses on research methods in public health and principles of public health at New York University. Dr. Kapadia received her doctorate in epidemiology from the Mailman School of Public Health at Columbia University in 2005.


Degrees Held

  • PhD - Columbia University, 2005
    (Epidemiology)
  • MPH - New York University, 1997
  • BS - SUNY Binghamton, 1995

Editorial Boards

Deputy Editor, American Journal of Public Health

Professional Affiliations

Society for Epidemiological Research

American Public Health Association

American College of Epidemiology

Awards

  • 2012 : New York University – Excellence in Public Health Faculty Award

Selected Publications

  • Kapadia F, Frye V, Bonner S, Emmanuel P, Samples C, Latka MH. Perceived peer safer sex norms and sexual risk behaviors among substance using Latino adolescents. AIDS Education and Prevention. 2012;24(1):27-40. (link)
  • Drumright LN, Hagan H, Thomas DL, Latka MH, Golub ET, Garfein RS, Clapp JD, Campbell JV, Bonner S, Kapadia F, Thiel TK, Strathdee SA. Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. Journal of Hepatology. 2011 Jul;55(1):45-52. (link)
  • Kapadia F, Finer LB, Klukas E. Associations between perceived partner support and relationship dynamics with timing of pregnancy termination. Womens Health Issues. 2011 May-Jun;21(3 Suppl):S8-13. (link)
  • Silver D, Mijanovich T, Uyei J, Kapadia F, Weitzman B. Disparities in childhood mortality among top 100 cities in the U.S. American Journal of Public Health. 2011 Feb;101(2):278-84. (link)
  • Kapadia F, Latka MH, Wu Y, Strathdee SA, Mackesy-Amiti M, Hudson SM, Thiede H, Garfein R for the CIDUS III-DUIT team. Longitudinal Determinants of Consistent Condom Use by Partner Type Among Young Injection Drug Users: The Role of Personal and Partner Characteristics. AIDS & Behavior. AIDS Behav. 2009 May 16. [Epub ahead of print] (link)
  • Latka MH, Kapadia F, Fortin P. The Female Condom: Effectiveness and Convenience, not "Female Control" Valued by US Urban Adolescents. AIDS Education and Prevention. 2008 Apr;20(2):160-70. (link)
  • Latka MH, Hagan H, Kapadia F, Golub ET, Bonner S, Cambell JV, Coady MH, Garfein RS, Pu, M, Thomas DL, Thiel T, Strathdee SS. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. American Journal of Public Health. 2008;98(5):853-61. (link)
  • Kapadia F, Vlahov D, Wu Y, Cohen MH, Greenblatt RM, Howard AA, Cook JA, Goparaju L, Golub E, Richardson J, Wilson TE. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. American Journal of Drug and Alcohol Abuse. 2008;34(2):161-70. (link)
  • Garfein RS, Golub ET, Greenberg A, Hagan H, Hanson DL, Hudson S, Kapadia F, Latka MH, Ouellet L, Purcell DW, Strathdee SA, Thiede H, for the DUIT Study Team. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS. 2007;21:1923-32. (link)
  • Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, Strathdee SA, Williams IT, Bailey SL, Hagan H, Golub ET, Kerndt P, Hanson DL, Latka MH for the DUIT Study Team. Methods to Recruit and Retain a Cohort of Young-Adult Injection Drug Users for The Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug and Alcohol Dependence. 2007;91(S1):S4-S17. (link)
  • Coady MH, Latka MH, Thiede H, Golub ET, Ouellet L, Hudson SM, Kapadia F, Garfein RS Housing status and associated differences in HIV risk behaviors among young injection drug users (IDUs). AIDS and Behavior. 2007;6:854-63. (link)
  • Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM, Kapadia F, Garfein RS for the DUIT Study Team. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug and Alcohol Dependence. 2007;91(S1):S39-S47. (link)
  • Kapadia F, Latka MH, Hagan H, Golub ET, Campbell JV, Coady MH, Garfein RS, Thomas DL, Bonner S, Thiel T, Strathdee SA. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health care access among hepatitis C virus positive injection drug users: The Study to Reduce Intravenous Exposures (STRIVE). Journal of Urban Health. 2007;84:99-115 (link)
  • Kapadia F, Latka MH, Hudson SM, Golub ET, Campbell JV, Bailey S, Frye V and Garfein RS for the CIDUS III/DUIT Team. Correlates of consistent condom use with main partners by partnership patterns among male injection drug users from 5 US cities. Drug and Alcohol Dependence. 2007;91(S1):S56-S63. (link)
  • Cook JA, Grey DD, Burke-Miller JK, Cohen MH, Vlahov D, Kapadia F, Wilson TE, Cook R, Schwartz RM, Golub ET, Anastos K, Ponath C, Goparaju L, Levine AM. Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug and Alcohol Dependence. 2007;89:74-81. (link)
  • Hagan H, Campbell JV, Thiede H, Strathdee SA, Ouellet L, Kapadia F, Hudson SM, Garfein RS. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Reports. 2006;121:710-719. (link)
  • Hagan H, Latka MH, Campbell JV, Golub ET, Garfein RS, Thomas DA, Kapadia F, Strathdee SA for the STRIVE Project Team. Eligibility for treatment of hepatitis C virus infection among young injection drug users in three US cities. Clinical Infectious Diseases. 2006;42(5):669-72. (link)
  • Kapadia F, Cook JA, Cohen MH Sohler N, Kovacs A, Greenblatt RM, Choudhary I, Vlahov D. The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction. 2005;100:990-1002. (link)
  • Kapadia F, Vlahov D, Donahoe RM, Friedland G. The Role of Substance Use in HIV Progression: Reconciling Differences from Laboratory and Epidemiologic Investigations. Clinical Infectious Diseases. 2005;41:1027-34. (link)
  • Strathdee SA, Latka M, Campbell J O’Driscoll PT, Golub ET, Kapadia F, Pollini RA, Garfein RS, Thomas DL, Hagan H; Study to Reduce Intravenous Exposures Project. Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. Clinical Infectious Diseases. 2005;40 Suppl 5:S304-12. (link)
  • Golub ET, Latka M, Hagan H, Havens JR, Hudson SM, Kapadia F, Campbell JV, Garfein RS, Thomas DL, Strathdee SA; STRIVE Project. Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. Journal of Urban Health. 2004;81(2):278-290. (link)
  • Weitzman BC, Guttmacher S, Weinberg S, Kapadia F. Low response rate schools in surveys of adolescent risk taking behaviours: possible biases, possible solutions. Journal of Epidemiology and Community Health. 2003;57(1):63-67. (link)
  • Kapadia F, Vlahov D, Des Jarlais DC, Strathdee SA, Ouellet L, Kerndt P, Morse E EV, Williams I, Garfein RS; Second Collaborative Injection Drug User Study (CIDUS-II) Group. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology. 2002;13(6):738-741. (link)
  • Guttmacher S, Weitzman BC, Kapadia F, Weinberg SL. Classroom-based surveys of adolescent risk-taking behaviors: reducing the bias of absenteeism. American Journal Public Health. 2002;92(2):235-237. (link)